Treatment Guidelines from The Medical Letter
Drugs for Asthma and COPD
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.


Patients whose symptoms are mild and infrequent can use a short-acting bronchodilator as needed for relief of symptoms. Patients with more frequent cough, wheeze, chest tightness or shortness of breath should begin treatment with a long-term controller medication. Low daily doses of an inhaled corticosteroid suppress airway inflammation and reduce the risk of exacerbations. For patients who remain symptomatic despite compliance with inhaled corticosteroid treatment and good inhalational technique, addition of a long-acting beta2-agonist is recommended. Patients with more severe disease may need higher doses of inhaled corticosteroids.Failure of pharmacologic treatment can often be attributed to lack of adherence to prescribed medications, uncontrolled co-morbid conditions such as allergic rhinitis, or continued exposure to tobacco smoke or other airborne pollutants, allergens or
... more      
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Asthma and COPD
Article code: 132a
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian